Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.

Saved in:

Bibliographic Details
Title:	Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Authors:	Belgiovine C; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy., Frapolli R; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Liguori M; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy., Digifico E; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy., Colombo FS; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy., Meroni M; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Allavena P; Humanitas Clinical and Research Center - IRCCS, via Manzoni 56, Rozzano, Milan, 20089, Italy., D'Incalci M; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Source:	European journal of immunology [Eur J Immunol] 2021 Nov; Vol. 51 (11), pp. 2677-2686. Date of Electronic Publication: 2021 Oct 08.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1521-4141
DOI:	10.1002/eji.202149379